GR3005276T3 - - Google Patents

Info

Publication number
GR3005276T3
GR3005276T3 GR920401606T GR920401606T GR3005276T3 GR 3005276 T3 GR3005276 T3 GR 3005276T3 GR 920401606 T GR920401606 T GR 920401606T GR 920401606 T GR920401606 T GR 920401606T GR 3005276 T3 GR3005276 T3 GR 3005276T3
Authority
GR
Greece
Prior art keywords
ulinastatin
platinum
side effects
kidney dysfunction
drugs
Prior art date
Application number
GR920401606T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3005276T3 publication Critical patent/GR3005276T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/005Enzyme inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR920401606T 1988-02-08 1992-07-29 GR3005276T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63026918A JPH01203334A (ja) 1988-02-08 1988-02-08 白金を含有する薬剤の副作用軽減剤

Publications (1)

Publication Number Publication Date
GR3005276T3 true GR3005276T3 (el) 1993-05-24

Family

ID=12206574

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920401606T GR3005276T3 (el) 1988-02-08 1992-07-29

Country Status (8)

Country Link
US (1) US4950465A (el)
EP (1) EP0327999B1 (el)
JP (1) JPH01203334A (el)
AT (1) ATE76754T1 (el)
AU (1) AU607584B2 (el)
CA (1) CA1329541C (el)
DE (1) DE68901656T2 (el)
GR (1) GR3005276T3 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466678A (en) * 1992-09-04 1995-11-14 Fuji Kagaku Kogyo Kabushiki Kaisha Co-administration of S-adenosyl-L-methionine to reduce the nephrotoxicity of cisplatin therapy
CN1160123C (zh) 2003-05-26 2004-08-04 广东天普生化医药股份有限公司 乌司他丁用于治疗严重急性呼吸综合征的用途及其药物组合物
BR112019025360A2 (pt) * 2017-05-30 2020-06-16 Nabriva Therapeutics Ireland DAC Métodos de identificação de novos regimes de dosagem
EP4114428A1 (en) 2020-03-05 2023-01-11 Diamedica USA Inc. Ulinastatin polypeptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6028928A (ja) * 1983-07-27 1985-02-14 Meiji Seika Kaisha Ltd 制癌剤の副作用軽減剤
IT1200467B (it) * 1985-05-06 1989-01-18 Boehringer Biochemia Srl Formulazione farmaceutica
JPS62106021A (ja) * 1985-11-01 1987-05-16 Eisai Co Ltd エラスタ−ゼの利用方法

Also Published As

Publication number Publication date
CA1329541C (en) 1994-05-17
JPH01203334A (ja) 1989-08-16
ATE76754T1 (de) 1992-06-15
EP0327999B1 (en) 1992-06-03
DE68901656D1 (de) 1992-07-09
EP0327999A1 (en) 1989-08-16
US4950465A (en) 1990-08-21
JPH0560813B2 (el) 1993-09-03
AU2955389A (en) 1989-08-10
AU607584B2 (en) 1991-03-07
DE68901656T2 (de) 1993-02-11

Similar Documents

Publication Publication Date Title
MY105328A (en) Blocking agents of edrf effect or formation for the treatment of shock.
DE68914856D1 (de) Synergetische Antioxydationsmischung.
AU1578688A (en) Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines
CS404781A2 (en) Zpusob vyroby kyselin 3 (4 (2 hydroxy 3 isopropylaminopropoxy)fenyl)alkanovych
AU6569190A (en) Pharmaceutical compositions for treating gastrointestinal distress
GB8920805D0 (en) An anti-diabetic pharmaceutical composition
AU8188691A (en) The use of inositoltrisphosphate for the preparing of medicaments
IL68456A0 (en) Pharmaceutical compositions comprising perfluorohydrocarbons as vehicles
CA2444071A1 (en) Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
MX9301707A (es) Composicion farmaceutica par inducir inmunosupresion.
DE3686022D1 (de) Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
GR3005870T3 (el)
GR3005276T3 (el)
DE3576505D1 (de) 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.
IL87778A0 (en) Pharmaceutical compositions containing stabilized therapeutically active proteins and their preparation
NZ214103A (en) Antimicrobial composition; synergistic mixture of maduramicin and nicarbazin
FI884838A0 (fi) Nytt s-timololderivat och foerfarande foer dess framstaellning.
DE69005241D1 (de) Calcitonin enthaltende pharmazeutische Zusammensetzungen.
JPS6431717A (en) Antitumor agent
IL85560A0 (en) Pharmaceutical compositions containing an antidepressant and a synergist
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
DK0608648T3 (da) Højdoserede vitamin A-præparater
KR900014954U (ko) V.t.r의 안전레버 오동작 방지장치
ATE50995T1 (de) 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.